Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3105 EUR | -4.75% | -2.97% | -20.38% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.38% | 14.4M | |
-1.82% | 41.35B | |
+42.55% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Rating